Atlas Trials

Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy

Clinical trial NCT03239535 · UNKNOWN

Trial details

NCT number
NCT03239535
Sponsor
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Critical Limb Ischemia
Start date
2013-10-01
Primary completion
2018-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.